您所在的位置: 2018年考研 > 考研英语 > 模拟试题 > 正文


2018年考研 www.dddcs.com 来源:中公考研 | 更新时间:2018-01-18 16:20:26

  2018考研交流群 5862545852018考研交流群


  At 18, Ashanthi DeSilva of suburban Cleveland is a living symbol of one of the great intellectual achievements of the 20th century. Born with an extremely rare and usually fatal disorder that left her without a functioning immune system (the “bubble-boy disease,” named after an earlier victim who was kept alive for years in a sterile plastic tent), she was treated beginning in 1990 with a revolutionary new therapy that sought to correct the defect at its very source, in the genes of her white blood cells. It worked. Although her last gene-therapy treatment was in 1992, she is completely healthy with normal immune function, according to one of the doctors who treated her, W. French Anderson of the University of Southern California. Researchers have long dreamed of treating diseases from hemophilia to cancer by replacing mutant genes with normal ones. And the dreaming may continue for decades more. “There will be a gene-based treatment for essentially every disease,” Anderson says, “within 50 years.”

  It's not entirely clear why medicine has been so slow to build on Anderson's early success. The National Institutes of Health budget office estimates it will spend $432 million on gene-therapy research in 2005, and there is no shortage of promising leads. The therapeutic genes are usually delivered through viruses that don't cause human disease. “The virus is sort of like a Trojan horse,” says Ronald Crystal of New York Presbyterian/Weill Cornell Medical College. “The cargo is the gene.”

  At the University of Pennsylvania's Abramson Cancer Center, immunologist Carl June recently treated HIV patients with a gene intended to help their cells resist the infection. At Cornell University, researchers are pursuing gene-based therapies for Parkinson's disease and a rare hereditary disorder that destroys children's brain cells. At Stanford University and the Children's Hospital of Philadelphia, researchers are trying to figure out how to help patients with hemophilia who today must inject themselves with expensive clotting drugs for life. Animal experiments have shown great promise.

  But somehow, things get lost in the translation from laboratory to patient. In human trials of the hemophilia treatment, patients show a response at first, but it fades over time. And the field has still not recovered from the setback it suffered in 1999, when Jesse Gelsinger, an 18-year-old with a rare metabolic disorder, died after receiving an experimental gene therapy at the University of Pennsylvania. Some experts worry that the field will be tarnished further if the next people to benefit are not patients but athletes seeking an edge. This summer, researchers at the Salk Institute in San Diego said they had created a “marathon mouse” by implanting a gene that enhances running ability; already, officials at the World Anti-Doping Agency are preparing to test athletes for signs of “gene doping.” But the principle is the same, whether you're trying to help a healthy runner run faster or allow a muscular-dystrophy patient to walk. “Everybody recognizes that gene therapy is a very good idea,” says Crystal. “And eventually it's going to work.”

  1. The case of Ashanthi Desilva is mentioned in the text to ____________.

  [A] show the promise of gene-therapy

  [B] give an example of modern treatment for fatal diseases

  [C] introduce the achievement of Anderson and his team

  [D] explain how gene-based treatment works

  2. Anderson‘s early success has ________________.

  [A] greatly speeded the development of medicine

  [B] brought no immediate progress in the research of gene-therapy

  [C] promised a cure to every disease

  [D] made him a national hero

  3. Which of the following is true according to the text?

  [A] Ashanthi needs to receive gene-therapy treatment constantly.

  [B] Despite the huge funding, gene researches have shown few promises.

  [C] Therapeutic genes are carried by harmless viruses.

  [D] Gene-doping is encouraged by world agencies to help athletes get better scores.

  4. The word “tarnish” (line 5, paragraph 4) most probably means ____________.

  [A] affect

  [B] warn

  [C] trouble

  [D] stain

  5. From the text we can see that the author seems ___________.

  [A] optimistic

  [B] pessimistic

  [C] troubled

  [D] uncertain

  答案:A B C D A

  以上是中公考研为大家准备整理的“2018考研英语阅读模拟题(1)”的相关内容。另中公考研提醒大家2018考研招生简章、2018考研招生目录、2018考研大纲已陆续公布,中公考研将为大家及时提供相关资讯。另外,为了帮助考生更好地复习,中公考研为广大学子推出2018考研暑期集训营、半年集训营、保研课程系列备考专题,针对每一个科目要点进行深入的指导分析,还会根据每年的考研大纲进行针对性的分析哦~欢迎各位考生了 解咨询。同时,中公考研一直为大家推出考研直播课堂,足不出户就可以边听课边学习,为大家的考研梦想助力!
























  • 公共课
  • 专业课
课程系列 班次名称 价格 免费试听
考研政治网络课堂 2019考研政治基础精讲班 ¥199.00 免费试听
2019考研政治全程精讲班 ¥789.00 免费试听
考研英语网络课堂 2019考研英语一全程班 ¥789.00 免费试听
2019考研英语二全程班 ¥789.00 免费试听
考研数学网络课堂 2019考研数学一全程班 ¥789.00 免费试听
2018考研数学二全程班 ¥789.00 免费试听
2019考研数学三全程班 ¥789.00 免费试听
全程联报课程 2019考研政治+英一全程联报协议班 ¥999.00 免费试听
2019考研政治+英二全程联报协议班 ¥999.00 免费试听
2019考研政治+英一+数一全程联报协议班 ¥1299.00 免费试听

结合学员专业意向(兴趣爱好、未来职业等)、学习情况(日常学习表现、测试成绩)及学习潜力进行评估,帮助学员准确定位,提高成功率 GO>


中公考研研究院潜心研发攻克名校六大锦囊。锦囊一:M & UP专业院校定位体系;锦囊二:TOP教学体系;锦囊三:专业教研团队;锦囊 GO>





  • 英语题库
  • 政治题库
  • 数学题库
  • 专业课题库

英语一 2018 2017 2016 2015 2014 2013

英语二: 2018 2017 2016 2015 2014 2013

政 治: 2018 2017 2016 2015 2014 2013

单选题: 2018 2017 2016 2015 2014 2013

多选题: 2018 2017 2016 2015 2014 2013

分析题: 2018 2017 2016 2015 2014 2013

数学一: 2018 2017 2016 2015 2014 2013

数学二: 2018 2017 2016 2015 2014 2013

数学三: 2018 2017 2016 2015 2014 2013

心理学: 2018 2017 2016 2014 2013 2012

教育学: 2018 2017 2016 2014 2013 2012

管理类: 2018 2017 2016 2015 2014 2013

经济类: 2018 2017 2016 2015 2014 2013

西 医: 2016 2013 2012 2011 2010 2009





中公考研名师指导: 择校择专业 跨专业报考 1V1专业解答

英语作文 | 张家港房产网 | 免费注册即送体验金 | 百家乐网址 | 澳门赌博网站 | 娱乐城注册送体验金 | 赌博网站源码 | 太阳城官网开户 | 世界博彩公司 | 全天北京pk10赛车计划 | 博彩公司排名 | 中国周易网 | 澳门百家乐 | 博彩公司 | 足球博彩分析 | 北京赛车PK10计划 | 北京pk10冠军计划群 | 世界最大博彩公司 | 世界三大博彩公司 | 可以赌博的棋牌游戏 | 网上赌博网站 | 北京赛车pk10开奖结果历史记录 | 007发布网 | 澳门赌博网 | 合肥房产网,合肥房产,二手房,合肥房产交易信息网 | 天涯博客 | 最火软件站_提供免费软件下载 | 中国苗木网 | 盐城房产网 | 济南房地产资讯 |